FDA Investigator Bichsa T Tran

Bichsa T Tran has inspections in 4 countries as of 27 Oct 2023. Bichsa T Tran has collaborated with a combinined 4890 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
34
Last Inspection Date:
27 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
Switzerland, United States of America, India, Japan
Co-Investigator(s):
A Williams, Adam R Cooke, Ademola O Daramola, Alan P Kurtzberg, Alexandra B Pitkin, Amalia C Himaya, Amalia Himaya, Amanda L Fyles, Amir Alavi, Anastasia M Shields, Anderson, Andrea A Branche, Andrew K Haack, PhD, Andrew S Limson, Andy B Lee, Angela Shepas, Angele C Smith, Anita Narula, PhD, Anthony G Emerson, April C Inyard, April P Shaw, Arie C Menachem, Ariel Cruz Figueroa, Arsen Karapetyan, Ashar P Parikh, Barbara J Rincon, Barbara L Rogolsky, Barry Cherney, PhD, Benjamin S Liao, Bichsa T Nguyen, Bijoy Panicker, Binh T Nguyen, Blondell W Johnson, Bo Chi, PhD, Brian D Nicholson, Brien C Fox, Bryan A Galvez, Calvin B Koerner, Carla J Lundi, Carr Sharpe, Carrie A Hughes, Caryn M Everly, Caryn M Mcnab, Cassandra L Abellard, Charles M Edwards, Cheron M Portee, Christina K Theodorou, Christina V Santos, Claudia Mperez Kasmarski, Comyar Shoghi, Conner N Mann, Daniel J Roberts, Daniel W Cline, Darla J Christopher, Darren S Brown, David Serrano, Davinna Ligons, PhD, Dawn E Barkans, Deborah A Greco, Dejon N Harris, Diana M Rand, Diane Cvan Leeuwen, Diane L Raccasi, Dipesh K Shah, Doan T Nguyen, PharmD, Dogbeda F Mackenzie, Donna Ltartaglino Besone, Dr. Chunchang Fang, Dr. Mark J Seaton, PhD, Dr. Monica D Cooper, Durell L Giles, Dyana K Stone, Eileen A Liu, Elaine A Bunch, Elizabeth A Girard, Elizabeth Ad Girard, Evelyn Wong, F Alex Slizza, Finn A Slizza, Frances Namuswe, PhD, Frederick Fricke, Frederick L Fricke, Gabriel Craig, Gene D Arcy, Gregory A Berg, Haley H Seymour, Haley Seymour, Haroon Vohra (NMI), Hasan A Irier, PhD, Himanshu Gupta, PhD, Hinh T Nguyen, Hossein Khorshidi, PhD, Iris C Macinnes, Jacob W Reynolds, James A Barreto, James B Arnett, James C Maclaughlin, James P Stumpff, James R Fleckenstein, Jamie M Du, Jane S Wernberg, Janet Blount, Janet D Bart, Jasmine N Thompson, Jee Chung, PhD, Jeffery A Johnson, Jeffrey P Raimondi, Jennifer Gogley, Jennifer M Gogley, Jeremy W Rotton, Jessica L Pressley, Jinnie Kokiatkulkij, Jocelyn E Massey, Jocelyn E Sparks, Joe X Phillips, Joel D Hustedt, Joel Welch, PhD, Joey V Quitania, John A Gonzales, John A Gonzalez, John L Stevens, John R Myung, Jolanna A Norton, Joseph X Philips, Joseph X Phillips, Juanita Banuelos, Julia Ventura, Jun Park, PhD, Ka L Wong, Karen A Wolnik, Kari M Johansen, Katherine E Jacobitz, Katherine Szestypalow, Kathleen R Jones, PhD, Kathy Chiu, Kathy Kuo, Keith P Iams, Kelley, Kelvin Cheung, Kelvin X Sanders, Kendra A Biddick, Kenneth R Merritt, Kevin N Tran, Kham Phommachang, Kham Phommachanh, Kim Lthomas Cruse, Kirtida Patel, Lakecha N Lewis, Langer, Larry K Austin, Laura Fontan, MS, Lauren L Vajo, Lavender M Huskey, Lee, Leonard H Lavi, Lillie D Witcher, Lilly O Barton, Liming Zhang, Linda F Murphy, Linda L Ng, Linda Thai, Ling Yul Liu, Lixia Cai, Loretta J Jordan, Mai X Huynh, Marcia Britt Williams, Marco S Esteves, Marcus F Yambot, Marie Falcone, Marie T Falcone, Mariza M Jafary, Mariza M Jalary, Mark C Saale, Mark W Babbitt, Marvin D Jones, Matthew B Casale, Maurice M Sheehan, Maxyne T Lam, Michael D Garcia, Michael T Cyrus, Michelle A Marsh, Michelle J Hines, Michsa T Nguyen, Miguel A Martinez, Mihaly S Ligmond, Minh D Phan, Mohsen Rajabi Abhari, FDA, Muralidhara B Gavini, PhD, Nadeem I Chaudhry, Nayan J Patel, Nelly N Tran, Nicholas L Hunt, Nicholas Obiri, PhD, Nicola M Fenty Stewart, Nicole E Knowlton, Olusegun J Ajayi, Omotunde O Osunsanmi, Pabhu P Raju, Pal S Mayasandra, Paquita F Segarra, Paul A Bonneau, Peter C Chow, Peter S Diak, Philip F Istafanos, DMV, MS, Prabhu P Raju, Rajiv R Srivastava, Randall N Johnson, Raymond T Oji, Raymond W Brullo, Reba A Gates, Rebecca Rodriguez, Richmond K Yip, Robert C Coleman, Robert D Tollefsen, Robert Darius, Roger F Zabinski, Ronald L Koller, Ronda Lebland, Ross J Grigsby, Rumany C Penn, PharmD, Ruth A Williams, Saied A Asbagh, Sandra A Boyd, Sangeeta M Khurana, PhD, Santiago Gallardo Johnson, Santos E Camara, Sarah Arden, Scott R Nichols, PhD, Selene T Torres, Shannon B Ruelle, Shirley J Berryman, Sidney B Priesmeyer, Sonia R Peterson, Sonya L Karsik, Sparky L Bartee, Srinivas R Chennamaneni, PhD, Stanley Au, Steven E Porter, Jr, Steven Fong, MS, PhD, Sue Lee Chan, Sumit Sen, Sundy Ven, Taichun Qin, PhD, Tamala P Bogan, Tamala P Magee, Teresa I Navas, Teresa T Cain, Terrance L Thomas, Terri L Dodds, Thao T Kwan, Thao Tran, Thao X Tran, Theresa Kirkham (NMI), Thomas J Arista, Thomas R Beilke, Timothy P Lafave, Timothy T Kapsala, Tony J Wu, Torrance J Slayton, Tracey T Duong, Trudy R Papson, Truong Xuan Nguyen (Andy), Tuan A Nguyen, Uttaniti Limchumroon (Tom), Valerie L Whipp, Vashti E Bocker, Vickie L Anderson, Vien Q Le, Virgilio F Pacio, CSO, Walden H Lee, Walden Lee, Wenzheng Zhang, William J Leonard, Xiaohan Cai, PhD, Xiaohui Shen, Yasamin Ameri, Yumi J Hiramine, Yvette E Guillermo, Yvette Mlacour Davis, Yvonne C Wilkes, Yvonne Y Wu, Zachary A Bogorad, Zedong Dong, Zhaoyang Meng

Bichsa T Tran's Documents

Publish Date Document Type Title
September, 2003 FDA 483 Med-Pharmex, Inc - Form 483, 2003-09-12
April, 2012 FDA 483 Teva Parenteral Medicines, Inc. - Form 483, 2012-04-24
August, 2014 FDA 483 Amphastar Pharmaceuticals, Inc. - Form 483, 2014-08-08
February, 2004 EIR Defender SD Manufacturing LLC - EIR, 2004-02-24
July, 2004 EIR La Jolla Pharmaceutical Co. - EIR, 2004-07-23
July, 2016 FDA 483 Response Teva Parenteral Medicines, Inc. - Form 483R, 2016-08-19
July, 2016 EIR Teva Parenteral Medicines, Inc. - EIR, 2016-07-29
November, 2007 FDA 483 Abbott Vascular - Form 483, 2007-11-15
March, 2008 FDA 483 Alliance Medical Products, Inc. (dba Siegfried Irvine) - Form 483, 2008-03-11
November, 2006 FDA 483 Cephazone Pharma LLC - Form 483, 2006-11-06
April, 2012 EIR Teva Parenteral Medicines, Inc. - EIR, 2012-04-24
April, 2017 FDA 483 Nitto Avecia Pharma Services, Inc. - Form 483, 2017-04-21
October, 2006 FDA 483 Response UFAG Laboratorien AG - Form 483R, 2006-10-23
April, 2017 EIR Nitto Avecia Pharma Services, Inc. - EIR, 2017-04-21
December, 2003 FDA 483 Response Amgen, Inc - Form 483R, 2004-01-06
February, 2004 FDA 483 Defender SD Manufacturing LLC - Form 483, 2004-02-24
February, 2013 FDA 483 ADAMSON ANALYTICAL LABORATORIES INC - Form 483, 2013-02-07
July, 2016 FDA 483 Teva Parenteral Medicines, Inc. - Form 483, 2016-07-29
February, 2006 FDA 483 CATALENT SAN DIEGO, INC. - Form 483, 2006-02-23
February, 2006 FDA 483 Spectrum Pharmaceuticals, Inc. - Form 483, 2006-02-23
July, 2004 FDA 483 La Jolla Pharmaceutical Co. - Form 483, 2004-07-23
September, 2012 FDA 483 Titan Medical Enterprises, Inc. DBA U.S. Apothecary Labs - Form 483, 2012-09-12
December, 2003 EIR Amgen, Inc - EIR, 2003-12-12
December, 2003 FDA 483 Amgen, Inc - Form 483, 2003-12-12
October, 2006 FDA 483 UFAG Laboratorien AG - Form 483, 2006-10-09
October, 2006 EIR UFAG Laboratorien AG - EIR, 2006-10-09
May, 2004 FDA 483 Watson Laboratories, Inc. - Form 483, 2004-05-06

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more